, PharmEasy — one of India’s leading healthcare platforms — has released its latest report, “Diabetes: The Silent Killer Sweeping Across India.”
The study, based on data from January 2021 to September 2025, analyzed over 4 million diagnostic reports and 19 million medicine orders across 29 states and Union Territories. The findings underscore India’s growing diabetes burden and the urgent need for early detection and long-term management.
Key Findings
Nearly 1 in 3 HbA1c test results fall within the diabetic range.
1 in 4 individuals show signs of prediabetes.
Together, more than half of those tested exhibit some form of blood sugar irregularity.
“At PharmEasy, we witness every day how early testing and awareness can truly change lives,” said Gaurav Verma, Head of B2C, PharmEasy (API Holdings). “This report is more than data; it is a call for action. 1 in 2 people tested show high blood sugar levels, yet millions remain unaware of their risk. Through accessible testing, continuous monitoring, and medical guidance, we aim to empower every Indian to take charge of their health.”
A Silent Epidemic Rising Across Ages
The report shows that diabetes is no longer limited to older adults. Even individuals under 30 show elevated blood sugar levels. The prevalence peaks after age 60, with 8 in 10 individuals in the diabetic or prediabetic range.
“One of the most worrying trends is the shifting age profile of diabetes,” noted Dr. Animesh Choudhary (MBBS, MD). “We’re seeing complications like heart disease and kidney issues appear decades earlier. Prevention must start in childhood through healthy diets, regular activity, and emotional well-being.”
Gender & Regional Differences
Men (51.9%) exhibit slightly higher rates of high blood sugar than women (45.43%).
Insulin resistance — an early warning sign — was seen in 58% of all users.
Regionally, southern and coastal states report higher blood sugar levels:
Puducherry (63%)
Odisha (61%)
Tamil Nadu (56%)
Goa (54%)
Himachal Pradesh (41%) shows relatively lower numbers.
These patterns reflect lifestyle, dietary habits, and varying healthcare access across regions.
Diabetes Medicines Now Account for One-Third of All PharmEasy Orders
Chronic disease management has become a cornerstone of India’s healthcare system. Diabetes medicines now represent over one-third of all PharmEasy medicine orders, up from 25% in 2021 to 34% in 2024 — a striking indicator of India’s growing dependence on chronic medication.
Beyond Blood Sugar: The Hidden Impact
Among individuals with high blood sugar:
1 in 4 had thyroid abnormalities (mostly hypothyroidism)
1 in 3 showed liver function issues
Nearly half had kidney impairment
About 90% displayed abnormal lipid profiles, elevating heart disease risk
These findings emphasize the need for comprehensive metabolic screening beyond just sugar levels.
Early Intervention Works
Encouragingly, among those who retested within six months:
22% returned to normal sugar levels
61% maintained stable readings
This demonstrates that with consistent monitoring, medication, and lifestyle changes, diabetes can be managed effectively.
Conclusion
The PharmEasy Diabetes Report reinforces a clear message: Small, consistent actions can prevent big complications.
Regular screening, timely treatment, and awareness are key to reversing India’s diabetes trend.
.jpg)